In trading today, Eupraxia Pharmaceuticals Inc shares closed at $3.93 after opening the day at $4.05. It traded at a low of $3.87 to a high of $4.05.

Share prices eased -0.76 percent from the previous day's close of $3.96.

Today across North America, the TSX Composite closed -0.63% at 21873.72, the S&P 500 closed 1.20% at 5070.55, the Dow Jones Industrial Average closed 0.69% at 38503.69 and the Nasdaq Composite closed 1.59% at 15696.64.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

A total of 28,910 shares was traded during the last trading day, with total trades of 91. On average, Eupraxia Pharmaceuticals Inc has traded 62,248 shares in the last five days and 56,729 year-to-date.

The TSX market on the whole today saw 2,208 price advancers against 2,970 declines and 124 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.44 (April 18,2024). Moreover, in the last 12 months, Eupraxia Pharmaceuticals Inc's shares have dipped -34.72%, while they have shrunken -26.82% this year.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $141.06 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.17.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Currently, Eupraxia Pharmaceuticals Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..